NLRR1 Is a Potential Therapeutic Target in Neuroblastoma and MYCN-Driven Malignant Cancers

Atsushi Takatori(Chiba Cancer Center), Akira Nakagawara(Chiba Cancer Center)
Frontiers in Oncology
June 25, 2021
Cited by 2


Related Papers